Cargando…
Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic
ELIXIR, the European research infrastructure for life science data, provides open access to data, tools and workflows in the response to the COVID-19 pandemic. ELIXIR’s 23 nodes have reacted swiftly to support researchers in their combined efforts against the pandemic setting out three joint priorit...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225634/ https://www.ncbi.nlm.nih.gov/pubmed/32415272 http://dx.doi.org/10.1038/s41431-020-0637-5 |
_version_ | 1783534110902321152 |
---|---|
author | Blomberg, Niklas Lauer, Katharina B. |
author_facet | Blomberg, Niklas Lauer, Katharina B. |
author_sort | Blomberg, Niklas |
collection | PubMed |
description | ELIXIR, the European research infrastructure for life science data, provides open access to data, tools and workflows in the response to the COVID-19 pandemic. ELIXIR’s 23 nodes have reacted swiftly to support researchers in their combined efforts against the pandemic setting out three joint priorities: 1. Connecting national COVID-19 data platforms to create federated European COVID-19 Data Spaces; 2. Fostering good data management to make COVID-19 data open, FAIR and reusable over the long term; 3. Providing open tools, workflows and computational resources to drive reproducible and collaborative science. ELIXIR’s strategy is based on the support given by our national nodes - collectively spanning over 200 institutes - to research projects and on partnering with community initiatives to drive development and adoption of good data practice and community driven standards. ELIXIR Nodes provide support activities locally and internationally, from provisioning compute capabilities to helping collect viral sequence data from hospitals. Some Nodes have prioritised access to their national cloud and compute facilities for all COVID-19 research projects, while others have developed tools to search, access and share all data related to the pandemic in a national healthcare setting. |
format | Online Article Text |
id | pubmed-7225634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-72256342020-05-15 Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic Blomberg, Niklas Lauer, Katharina B. Eur J Hum Genet Policy ELIXIR, the European research infrastructure for life science data, provides open access to data, tools and workflows in the response to the COVID-19 pandemic. ELIXIR’s 23 nodes have reacted swiftly to support researchers in their combined efforts against the pandemic setting out three joint priorities: 1. Connecting national COVID-19 data platforms to create federated European COVID-19 Data Spaces; 2. Fostering good data management to make COVID-19 data open, FAIR and reusable over the long term; 3. Providing open tools, workflows and computational resources to drive reproducible and collaborative science. ELIXIR’s strategy is based on the support given by our national nodes - collectively spanning over 200 institutes - to research projects and on partnering with community initiatives to drive development and adoption of good data practice and community driven standards. ELIXIR Nodes provide support activities locally and internationally, from provisioning compute capabilities to helping collect viral sequence data from hospitals. Some Nodes have prioritised access to their national cloud and compute facilities for all COVID-19 research projects, while others have developed tools to search, access and share all data related to the pandemic in a national healthcare setting. Springer International Publishing 2020-05-15 2020-06 /pmc/articles/PMC7225634/ /pubmed/32415272 http://dx.doi.org/10.1038/s41431-020-0637-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Policy Blomberg, Niklas Lauer, Katharina B. Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic |
title | Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic |
title_full | Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic |
title_fullStr | Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic |
title_full_unstemmed | Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic |
title_short | Connecting data, tools and people across Europe: ELIXIR’s response to the COVID-19 pandemic |
title_sort | connecting data, tools and people across europe: elixir’s response to the covid-19 pandemic |
topic | Policy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225634/ https://www.ncbi.nlm.nih.gov/pubmed/32415272 http://dx.doi.org/10.1038/s41431-020-0637-5 |
work_keys_str_mv | AT blombergniklas connectingdatatoolsandpeopleacrosseuropeelixirsresponsetothecovid19pandemic AT lauerkatharinab connectingdatatoolsandpeopleacrosseuropeelixirsresponsetothecovid19pandemic |